Why the study?
Does oral hydralazine improve hemodynamic parameters in patients with chronic heart failure?
Population
11 patients with chronic heart failure
Comparison
Oral hydralazine for short-term and long-term… vs Baseline control values and withdrawal of…
Design
Cohort
Follow-up
average 8.3 months
Authors
Loading...
Observed hemodynamic gains with long-term hydralazine in chronic HF should not change practice; leaves open effects on clinical outcomes.
Does oral hydralazine improve hemodynamic parameters in patients with chronic heart failure?
Oral hydralazine produces sustained beneficial hemodynamic improvements in patients with chronic heart failure over an average of 8.3 months.
Kanu Chatterjee (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: